TLSA — Tiziana Life Sciences Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1723069 ·
Last close
$1.15
Market Cap
$146.35M
52W High
$1.58
52W Low
$0.87
ADV30
876,557
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 11,495,000 | 4,010,000 | 11,443,000 |
| Dec 2024 | — | — | — | — | 11,284,000 | 3,724,000 | 7,348,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-163,109,000
Inventory
—
Receivables
$4,257,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -21,132,000 | -18,431,000 | 11,495,000 | 11,443,000 | — | -12,847,000 |
| Dec 2024 | 0 | -15,794,000 | -11,863,000 | 11,284,000 | 7,348,000 | — | -1,526,000 |
| Dec 2023 | 0 | -17,984,000 | -17,691,000 | 12,184,000 | 6,648,000 | — | -15,698,000 |
| Dec 2022 | 0 | -14,586,000 | -15,397,000 | 26,477,000 | 6,906,000 | — | -19,615,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.20
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UNCY | Unicycive Therapeutics, Inc. | $146.28M | $5.34 | — |
| CNTB | Connect Biopharma Holdings Ltd | $144.84M | $2.30 | — |
| NRXP | NRX Pharmaceuticals, Inc. | $149.37M | $3.45 | — |
| SMNR | Semnur Pharmaceuticals, Inc. | $142.73M | $0.62 | — |
| AARD | Aardvark Therapeutics, Inc. | $150.57M | $6.88 | — |
News headlines (Yahoo Finance, 1h cache)
Tiziana Life Sciences to present Phase 2a BANYAN trial data at ALS Nexus 2026
2026-08-24 12:35 · Yahoo
Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026
2026-08-24 11:00 · Yahoo
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
2026-08-06 11:00 · Yahoo
Tiziana Life Sciences reports reductions in brain inflammation in third MSA patient
2026-07-31 12:55 · Yahoo
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
2026-07-31 11:00 · Yahoo
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
2026-07-22 11:00 · Yahoo
Tiziana Life Sciences doses last patient in Phase 2a multiple sclerosis trial
2026-06-25 13:05 · Yahoo
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
2026-06-25 11:00 · Yahoo
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
2026-05-28 11:00 · Yahoo
Wall Street ends on a mixed note as Dow gains despite semiconductor slump
2026-08-24 12:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.